New Tools for Epilepsy Therapy

One third of the epilepsies are refractory to conventional antiepileptic drugs (AEDs) and, therefore, identification of new therapies is highly needed. Here, we briefly describe two approaches, direct cell grafting and gene therapy, that may represent alternatives to conventional drugs for the treat...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in cellular neuroscience Vol. 12; p. 147
Main Authors: Falcicchia, Chiara, Simonato, Michele, Verlengia, Gianluca
Format: Journal Article
Language:English
Published: Switzerland Frontiers Research Foundation 29-05-2018
Frontiers Media S.A
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:One third of the epilepsies are refractory to conventional antiepileptic drugs (AEDs) and, therefore, identification of new therapies is highly needed. Here, we briefly describe two approaches, direct cell grafting and gene therapy, that may represent alternatives to conventional drugs for the treatment of focal epilepsies. In addition, we discuss more in detail some new tools, cell based-biodelivery systems (encapsulated cell biodelivery (ECB) devices) and new generation gene therapy vectors, which may help in the progress toward clinical translation. The field is advancing rapidly, and there is optimism that cell and/or gene therapy strategies will soon be ready for testing in drug-resistant epileptic patients.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Reviewed by: Gabriele Losi, Istituto di Neuroscienze (IN), Italy; Alfonso Represa, INSERM U901 Institut de Neurobiologie de la Méditerranée, France
Edited by: Marco Ledri, Lund University, Sweden
ISSN:1662-5102
1662-5102
DOI:10.3389/fncel.2018.00147